These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12365409)

  • 1. A vaccine to prevent infections with Staphylococcus aureus.
    Thiemermann C
    Med Sci Monit; 2002 Sep; 8(9):LE35-6. PubMed ID: 12365409
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparation of delayed-action staphylococcal vaccine. I. Effect of the vaccine on local skin infection in rabbits].
    Giedrys-Galant S; Hałasa J; Podkowińska I
    Med Dosw Mikrobiol; 1984; 36(2):77-85. PubMed ID: 6492938
    [No Abstract]   [Full Text] [Related]  

  • 3. Staphylococcus aureus antigens and challenges in vaccine development.
    Middleton JR
    Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of delayed-action staphylococcal vaccine. II. Effect of the vaccine on the course of generalized infection in mice].
    Giedrys-Galant S; Hałasa J; Podkowińska I
    Med Dosw Mikrobiol; 1984; 36(2):87-91. PubMed ID: 6492939
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there a future for a Staphylococcus aureus vaccine?
    Proctor RA
    Vaccine; 2012 Apr; 30(19):2921-7. PubMed ID: 22115633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Staphylococcus aureus infections: advances in vaccine development.
    Shinefield HR; Black S
    Expert Rev Vaccines; 2005 Oct; 4(5):669-76. PubMed ID: 16221068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal vaccines and immunotherapy: to dream the impossible dream?
    Projan SJ; Nesin M; Dunman PM
    Curr Opin Pharmacol; 2006 Oct; 6(5):473-9. PubMed ID: 16870507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for active and passive immunization against Staphylococcus aureus.
    Shinefield HR; Black S
    Pediatr Infect Dis J; 2006 Feb; 25(2):167-8. PubMed ID: 16462297
    [No Abstract]   [Full Text] [Related]  

  • 9. Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin.
    Kernodle DS
    J Infect Dis; 2011 Jun; 203(11):1692-3; author reply 1693-4. PubMed ID: 21593000
    [No Abstract]   [Full Text] [Related]  

  • 10. Challenges for a universal Staphylococcus aureus vaccine.
    Proctor RA
    Clin Infect Dis; 2012 Apr; 54(8):1179-86. PubMed ID: 22354924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for a MRSA vaccine.
    Lindsay JA
    Future Microbiol; 2007 Feb; 2(1):1-3. PubMed ID: 17661669
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine design.
    Nanra JS; Timofeyeva Y; Buitrago SM; Sellman BR; Dilts DA; Fink P; Nunez L; Hagen M; Matsuka YV; Mininni T; Zhu D; Pavliak V; Green BA; Jansen KU; Anderson AS
    Vaccine; 2009 May; 27(25-26):3276-80. PubMed ID: 19200819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.
    Broughan J; Anderson R; Anderson AS
    Expert Rev Vaccines; 2011 May; 10(5):695-708. PubMed ID: 21604989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity induced by Staphylococcus aureus surface protein A was protective against lethal challenge of Staphylococcus aureus in BALB/c mice.
    Yi SQ; Zhang XY; Yang YL; Yang Y; Liu SL; Fu L; Yu CM; Chen W
    Microbiol Immunol; 2012 Jun; 56(6):406-10. PubMed ID: 22420921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the immune proteome of Staphylococcus aureus - The anti-S. aureus antibody response.
    Holtfreter S; Kolata J; Bröker BM
    Int J Med Microbiol; 2010 Feb; 300(2-3):176-92. PubMed ID: 19889576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Staphylococcus aureus immunotherapy: current status and prospects.
    García-Lara J; Foster SJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):552-7. PubMed ID: 19733119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine could help fight deadly hospital-acquired infections.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Mar; 13(6):9-10, 12. PubMed ID: 12449105
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination and passive immunisation against Staphylococcus aureus.
    Schaffer AC; Lee JC
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSCRAMM--targeted vaccines and immunotherapy for staphylococcal infection.
    Rivas JM; Speziale P; Patti JM; Höök M
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):223-7. PubMed ID: 15603256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention and immunotherapy of staphylococcal infections with bacterial vaccines].
    Kuz'menko OM; Gruber IM; Priiatkin RG
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (5):106-12. PubMed ID: 21061586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.